Last updated: 2026-09-16 12:10:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Sera Prognostics, Inc. (SERA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2.02, with a market capitalisation of $78.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.56 to $3.95. This page covers its latest market performance, valuation, price trends and company information.
$78.90M | |
$1.97 | |
$15.50 | |
$1.10 | |
$2.00 | |
24.92K | |
33.49K | |
-- | |
$3.95 | |
$1.56 | |
-- | |
-- |
Sera Prognostics, Inc. (SERA) is trading at $2.07 in pre-market trading as of 2026-09-15 20:11:00, up 3.50% ($0.07) from the previous close of $2.00
Pre-market trading shows how investors are pricing SERA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Sera Prognostics, Inc. (SERA) moved from $2.02 to $2.02, representing a decline of 0.15% ($0.00).
The stock traded between $1.96 and $2.07 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 34.09 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 19.1%
SERA is currently trading at $2.02, placing it 19.1% of the way from its 52-week low of $1.56 to its 52-week high of $3.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 72 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sera Prognostics, Inc. (SERA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.